• Instagram icon with link to IfADo's Instagram presence
  • X-Twitter icon with link to IfADo's X.com presence
  • Facebook icon with link to IfADo's Facebook presence
  • YouTube icon with link to IfADo's YouTube channel
  • LinkedIn icon with link to IfADo's LinkedIn presence
  • Mastodon icon with link to IfADo's Mastodon presence

Dr. Reham Hassan Reyad Khalil Alkashef

Scientific staff

Head of department
Prof. Dr. Jan G. Hengstler
Secretariat
Monika Turajski
Address
Ardeystr. 67
44139 Dortmund

Here you will find the Publications from 2010 onwards.

Hassan R, Ghallab A:
Highlight report: Humanized mice reveal interspecies differences in triclosan hepatotoxicity. (Editorial). Arch Toxicol 92: 3607–3608 (2018)
Hassan R:
Highlight report: The EDI3-GPAM axis in tumor cell migration. (Guest editorial). EXCLI J 16: 1148-1149 (2017)
Hassan R:
Highlight report: Adaptations of the biliary tree to cholestasis. (Editorial). Arch Toxicol 91: 3207-3208 (2017)
Leist M, Ghallab A, Graepel R, Marchan R, Hassan R, Bennekou SH, Limonciel A, Vinken M, Schildknecht S, Waldmann T, Danen E, van Ravenzwaay B, Kamp H, Gardner I, Godoy P, Bois FY, Braeuning A, Reif R, Oesch F, Drasdo D, Höhme S, Schwarz M, Hartung T, Braunbeck T, Beltman J, Vrieling H, Sanz F, Forsby A, Gadaleta D, Fisher C, Kelm J, Fluri D, Ecker G, Zdrazil B, Terron A, Jennings P, van der Burg B, Dooley S, Meijer AH, Willighagen E, Martens M, Evelo C, Mombelli E, Taboureau O, Mantovani A, Hardy B, Koch B, Escher S, van Thriel C, Cadenas C, Kroese D, van de Water B, Hengstler JG:
Adverse outcome pathways: opportunities, limitations and open questions. Arch Toxicol 91: 3477-3505 (2017)
Schenk A, Ghallab A, Hofmann U, Hassan R, Schwarz M, Schuppert A, Schwen LO, Braeuning A, Teutonico D, Hengstler JG, Kuepfer L:
Physiologically-based modelling in mice suggests an aggravated loss of clearance capacity after toxic liver damage. Sci Rep 7(1): 6224 (2017) (13 pp)
Selinski S, Blaszkewicz M, Lehmann ML, Ovsiannikov D, Moormann O, Guballa C, Kress A, Truss MC, Gerullis H, Otto T, Barski D, Niegisch G, Albers P, Frees S, Brenner W, Thüroff JW, Angeli-Greaves M, Seidel T, Roth G, Dietrich H, Ebbinghaus R, Prager HM, Bolt HM, Falkenstein M, Zimmermann A, Klein T, Reckwitz T, Roemer HC, Löhlein D, Weistenhöfer W, Schöps W, Hassan Rizvi SA, Aslam M, Bánfi G, Romics I, Steffens M, Ekici AB, Winterpacht A, Ickstadt K, Schwender H, Hengstler JG, Golka K:
Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype. Pharmacogenet Genomics 21: 673-678 (2011)